Company: MLTX
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001821586-25-000011
Chunk: 89

Company: MoonLake Immunotherapeutics
Filing Date: 2025-05-12
Form: 10-Q
Item: Part II, Item 2
Chunk 89
---
base Document.101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document.101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document.104*Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*    Filed herewith.

**    Furnished.

#    Portions of the Exhibit have been omitted because they are both (i) customarily and actually treated as private and confidential and (ii) not material.

+    Indicates a management contract or compensatory plan.

48

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

MOONLAKE IMMUNOTHERAPEUTICS/s/ Dr. Jorge Santos da SilvaDate:May 12, 2025Name:Dr. Jorge Santos da SilvaTitle:Chief Executive Officer(Principal Executive Officer)/s/ Matthias BodenstedtDate:May 12, 2025Name:Matthias BodenstedtTitle:Chief Financial Officer(Principal Financial and Accounting Officer)

49